Everyone online is suddenly injecting peptides. But almost nobody understands the scienceor the regulation. The FDA recently shifted several peptides off the Category 2 safety risk list tied to compounding rules. First, that In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Orthopaedic relevant peptides, reported effects, and current regulatory Download Scientific Diagram Is BPC 157 Legal? Understanding Its Status and Implications BPC 157 for ACL recovery: hype vs. science Adam C. Cady MHS, ATC, CSCS, PA C posted on the topic LinkedIn